Trial Profile
Study of edaravone prevention for post stroke dementia
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Apr 2016
Price :
$35
*
At a glance
- Drugs Edaravone (Primary)
- Indications Mild cognitive impairment; Vascular dementia
- Focus Therapeutic Use
- 14 May 2013 New trial record